Renaissance Capital logo

Tranzyme , Nasdaq: TZYM

Developing small molecule therapeutics to treat gastrointestinal disorders.

Industry: Health Care

First Day Return: 0.0%

Industry: Health Care

Developing small molecule therapeutics to treat gastrointestinal disorders.
more less
IPO Data
IPO File Date 11/19/2010
Offer Price $4.00
Price Range $4.00 - $4.00
Offer Shares (mm) 13.5
Deal Size ($mm) $54
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 04/01/2011
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $54
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Durham, NC, United States
Founded 1998
Employees at IPO 39
Website www.tranzyme.com

Tranzyme (TZYM) Performance